AKIBAT HUKUM PENISTAAN AGAMA YANG BERLEBELKAN PROMOSI MINUMAN KERAS MUHAMMAD DAN MARIA DARI HOLYWINGS
SUPREMASI HUKUM · 04.07.2025 · 21 (02) · 14-23
DOI: 10.33592/sh.v21i02.3081 ↗Kurz gefasst
Fachartikel in der Zeitschrift SUPREMASI HUKUM, online erschienen am 04.07.2025. Verfasst von Dedeh Kurnia und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
This journal examines the legal consequences of alleged blasphemy involving Holywings’ liquor promotion labeled with the names Muhammad and Maria, as well as the police’s role in preventing acts of blasphemy. The study aims to identify the legal consequences of the promotion and analyze the role of the police in preventing religious blasphemy. It employs normative legal research, which examines legal issues through scientific legal reasoning, literature reviews, legal doctrines, and the study of legal documents. The findings highlight that blasphemy is regulated under Law Number 1 of 1965 concerning the Prevention of Abuse and/or Blasphemy of Religion and Article 156a of the Indonesian Criminal Code (KUHP). These legal provisions provide the framework for addressing acts of religious blasphemy under Indonesian law. Keywords: Legal Concequences; Blasphemy of Religion; Promotional Labels; Hollywings.
Zitieren
APA
Kurnia, D., & Faridah, H. (2025). AKIBAT HUKUM PENISTAAN AGAMA YANG BERLEBELKAN PROMOSI MINUMAN KERAS MUHAMMAD DAN MARIA DARI HOLYWINGS. SUPREMASI HUKUM, 21(02), 14-23. https://doi.org/10.33592/sh.v21i02.3081
Vancouver
Kurnia D, Faridah H. AKIBAT HUKUM PENISTAAN AGAMA YANG BERLEBELKAN PROMOSI MINUMAN KERAS MUHAMMAD DAN MARIA DARI HOLYWINGS. SUPREMASI HUKUM. 2025;21(02):14-23. doi:10.33592/sh.v21i02.3081
BibTeX
@article{Kurnia2025,
author = {Kurnia, Dedeh and Faridah, Hana},
title = {AKIBAT HUKUM PENISTAAN AGAMA YANG BERLEBELKAN PROMOSI MINUMAN KERAS MUHAMMAD DAN MARIA DARI HOLYWINGS},
journal = {SUPREMASI HUKUM},
year = {2025},
volume = {21},
number = {02},
pages = {14--23},
doi = {10.33592/sh.v21i02.3081}
}
EUVIMED